Antisense-MDM2 Sensitizes LNCaP Prostate Cancer Cells to Androgen Deprivation, Radiation, and the Combination In Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antisense-MDM2 Sensitizes LNCaP Prostate Cancer Cells to Androgen Deprivation, Radiation, and the Combination In Vivo

Published:2007-07 Issue:4 Volume:68 Page:1151-1160
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Stoyanova Radka,Hachem Paul,Hensley Harvey,Khor Li-Yan,Mu Zhaomei,Hammond M. Elizabeth H.,Agrawal Sudhir,Pollack Alan

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference52 articles.

1. Inactivation of the p53 pathway in prostate cancer: Impact on tumor progression;Osman;Clin Cancer Res,1999

2. Abnormal expression of MDM2 in prostate carcinoma;Leite;Mod Pathol,2001

3. MDM2 as a predictor of prostate carcinoma outcome: An analysis of Radiation Therapy Oncology Group Protocol 8610;Khor;Cancer,2005

4. Mdm2 promotes the rapid degradation of p53;Haupt;Nature,1997

5. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53;Honda;FEBS Lett,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses;Molecular Cancer Research;2020-05-04

2. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner;Neoplasia;2016-04

3. Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity;Molecular Cancer Therapeutics;2016-03-04

4. An in-vivo investigation of the therapeutic effect of pulsed focused ultrasound on tumor growth;Medical Physics;2014-11-12

5. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo;Cancer Letters;2014-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3